AI Article Synopsis
- Ischemia-modified albumin (IMA) serves as a marker for myocardial ischemia, assessed through the albumin cobalt binding test.
- After elective cardioversion for atrial fibrillation, IMA concentrations were measured to check for signs of transient myocardial ischemia.
- Patients exhibiting electrocardiographic changes, like ST-depression or T-wave inversion, showed significantly higher IMA levels, indicating possible transient myocardial ischemia post-cardioversion.*
Article Abstract
Ischemia-modified albumin (IMA), measured with the albumin cobalt binding test, is a marker of myocardial ischemia. We measured IMA concentrations after elective direct-current cardioversion for atrial fibrillation to determine whether transient myocardial ischemia occurs. Patients with electrocardiographic changes after cardioversion (ST-depression and/or T-wave inversion) had significantly higher IMA levels than those without these changes. Thus, elevated levels of IMA after cardioversion may reflect transient myocardial ischemia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.amjcard.2003.10.023 | DOI Listing |
Publication Analysis
Top Keywords
myocardial ischemia
12
direct-current cardioversion
8
ischemia-modified albumin
8
atrial fibrillation
8
transient myocardial
8
cardioversion ischemia-modified
4
albumin levels
4
levels patients
4
patients atrial
4
fibrillation ischemia-modified
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!